16 min listen
Patient discussion at EHA 2018: CAR T-cells and MRD in CLL
FromVJHemOnc Podcast
ratings:
Length:
11 minutes
Released:
Sep 14, 2018
Format:
Podcast episode
Description
CAR T-cells have demonstrated impressive efficacy in a variety of hematological malignancies, but their use in chronic lymphocytic leukemia (CLL)...
The post Patient discussion at EHA 2018: CAR T-cells and MRD in CLL appeared first on VJHemOnc.
The post Patient discussion at EHA 2018: CAR T-cells and MRD in CLL appeared first on VJHemOnc.
Released:
Sep 14, 2018
Format:
Podcast episode
Titles in the series (100)
CAR T-cells in myeloma: exploratory targets, payment models & treatment sequence: CAR T-cell therapy presents the opportunity to completely revolutionize the treatment of multiple myeloma, with research currently exploring the optimal... by VJHemOnc Podcast